{"id":61922,"date":"2025-09-25T13:05:04","date_gmt":"2025-09-25T11:05:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/"},"modified":"2025-09-25T13:05:04","modified_gmt":"2025-09-25T11:05:04","slug":"survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/","title":{"rendered":"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Eight in 10 adults agree that adult smokers should have access to smoke-free options, while 76% worry that decisions are based on ideology rather than science and facts<\/i><\/p>\n<p>STAMFORD, Conn.&#8211;(BUSINESS WIRE)&#8211;A new international survey conducted by Povaddo and commissioned by Philip Morris International Inc. (NYSE: PM) reveals strong global support for smoke-free alternatives to cigarettes and growing worries about how public health decisions are made.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/5\/PMI_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/22\/PMI_logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/5\/PMI_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/21\/PMI_logo.jpg\"><\/a><\/p>\n<p>\nThe survey found that 78% of respondents agree that adult smokers in all countries should have access to better alternatives to continued smoking. Approximately three-quarters (74%) believe that encouraging people who smoke to switch to these products can help improve public health.<\/p>\n<p>\nAlarmingly, current policies in many countries stand in the way of allowing legal-age adults to switch to scientifically substantiated better alternatives. Approximately three-quarters of respondents (76%) expressed concern that decisions are being made based on ideology rather than science and facts. Almost 8 in 10 (78%) would like their governments to first consider the science behind smoke-free alternatives\u2014and how these products have reduced smoking rates in other countries\u2014before imposing restrictions. This sentiment is particularly strong in countries where all or some of these products are banned, including Argentina (83%), Brazil (82%) and India (94%).<\/p>\n<p>\n<i>\u201cProgress matters. Countries that embrace smoke-free products have seen declines in cigarette sales and smoking rates,\u201d <\/i>said Jacek Olczak, Chief Executive Officer of Philip Morris International<i>. \u201cThere is strong demand globally for governments to adopt fact-based policies that keep pace with innovation and deliver better outcomes for society.\u201d<\/i><\/p>\n<p>\n<b>Key findings<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nAround three-quarters of the survey respondents (76%) are very or somewhat concerned that decisions are being made based on ideology instead of science and facts.<\/li>\n<li>\nNearly 9 in 10 (87%) say it is very or somewhat important for governments to make public health decisions based on science instead of ideology.<\/li>\n<li>\nSix in 10 (58%) agree it is wrong for governments to ban or severely restrict the sale of less harmful alternatives while cigarette sales remain legal. Agreement in countries that have banned all or some smoke-free products stands at: Argentina (61%), Brazil (61%), and India (73%).<\/li>\n<li>\nSix in 10 (61%) also agree it is a public health failure that 29% of the global adult population lives in a country where all or some smoke-free alternatives are banned.<\/li>\n<li>\nFour in five (80%) believe public health organizations have a responsibility to share all available evidence on smoke-free alternatives rather than selectively citing data.<\/li>\n<li>\nJust over three-quarters (77%) of respondents outside Sweden think their country should follow Sweden\u2019s approach to smoke-free alternatives.<\/li>\n<li>\nMore than 8 in 10 (82%) legal-age smokers in countries where all or some smoke-free products are banned would like the opportunity to buy them legally.<\/li>\n<\/ul>\n<p>\nToday, more than 190 million smokers<sup>1<\/sup> in more than 20 countries\u2014nearly one in five globally\u2014have no legal access to a range of smoke-free products, even though cigarettes\u2014the most harmful way to consume nicotine\u2014remain widely available. In many of these countries declines in smoking rates have stagnated despite advertising bans, high excise taxes, plain packaging, and a complete flavor ban on cigarettes.<\/p>\n<p>\nFind out more here: <a target=\"_blank\" href=\"https:\/\/eur03.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.pmi.com%2Fprogressmatters&amp;data=05%7C02%7CRadoslav.Hristov%40pmi.com%7C184e46d97e9c4d8636f408ddf91d9bb9%7C8b86a65e3c3a44068ac319a6b5cc52bc%7C0%7C0%7C638940627733155916%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=SVouJippJB51rIOrhIdOnfOOzStAwCQAT2pCxJV0ZSc%3D&amp;reserved=0\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.pmi.com\/progressmatters<\/a><\/p>\n<p>\n<b>About the Study<\/b><\/p>\n<p>\nPovaddo fielded the survey among adults aged 21 and older between September 11 and 17, 2025, in 9 countries: Argentina, Brazil, Germany, India, Italy, Japan, Sweden, the United Kingdom, and the United States. The sample size was 9,040 (approximately 1,000 per country).<\/p>\n<p>\n<b>Philip Morris International: A Global Smoke-Free Champion<\/b><\/p>\n<p>\nPhilip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company\u2019s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch, and e-vapor products. As of June 30, 2025, our smoke-free products were available for sale in 97 markets, and PMI estimates they were used by over 41 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 41% of PMI\u2019s first-half 2025 total net revenues. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate, and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match\u2019s <i>General <\/i>snus and <i>ZYN <\/i>nicotine pouches, and versions of PMI\u2019s <i>IQOS <\/i>devices and consumables\u2014the first-ever such authorizations in their respective categories. Versions of <i>IQOS <\/i>devices and consumables<i> <\/i>and <i>General<\/i> snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to \u201cPMI,\u201d \u201cwe,\u201d \u201cour,\u201d and \u201cus\u201d mean Philip Morris International Inc. and its subsidiaries. For more information, please visit <a target=\"_blank\" href=\"http:\/\/www.pmi.com\/\" rel=\"nofollow\" shape=\"rect\"><b>www.pmi.com<\/b><\/a> and <a target=\"_blank\" href=\"http:\/\/www.pmiscience.com\/\" rel=\"nofollow\" shape=\"rect\"><b>www.pmiscience.com<\/b><\/a>.<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">___________________________<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<sup>1 <\/sup>WHO Global report on trends in prevalence of tobacco use 2000 \u2013 2030 <a target=\"_blank\" href=\"https:\/\/iris.who.int\/bitstream\/handle\/10665\/375711\/9789240088283-eng.pdf?sequence=1\" rel=\"nofollow\" shape=\"rect\">9789240088283-eng.pdf<\/a><\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n\u00a0<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nDavid Fraser<br \/>\n<br \/>Philip Morris International<br \/>\n<br \/>T. +41 (0)58 242 4500<br \/>\n<br \/>E. <a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;t&#111;&#x3a;&#100;&#x61;v&#105;&#x64;&#46;&#x66;r&#x61;&#x73;&#101;&#x72;&#64;&#x70;m&#105;&#x2e;&#99;&#x6f;m\" rel=\"nofollow\" shape=\"rect\">&#x64;&#x61;&#118;i&#x64;&#x2e;&#102;&#114;a&#x73;&#x65;&#114;&#64;p&#x6d;&#x69;&#46;co&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Eight in 10 adults agree that adult smokers should have access to smoke-free options, while 76% worry that decisions are based on ideology rather than science and facts STAMFORD, Conn.&#8211;(BUSINESS WIRE)&#8211;A new international survey conducted by Povaddo and commissioned by Philip Morris International Inc. (NYSE: PM) reveals strong global support for smoke-free alternatives to cigarettes &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61922","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Eight in 10 adults agree that adult smokers should have access to smoke-free options, while 76% worry that decisions are based on ideology rather than science and facts STAMFORD, Conn.&#8211;(BUSINESS WIRE)&#8211;A new international survey conducted by Povaddo and commissioned by Philip Morris International Inc. (NYSE: PM) reveals strong global support for smoke-free alternatives to cigarettes ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-25T11:05:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/22\/PMI_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking\",\"datePublished\":\"2025-09-25T11:05:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/\"},\"wordCount\":865,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250925818926\\\/en\\\/328938\\\/22\\\/PMI_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/\",\"name\":\"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250925818926\\\/en\\\/328938\\\/22\\\/PMI_logo.jpg\",\"datePublished\":\"2025-09-25T11:05:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250925818926\\\/en\\\/328938\\\/22\\\/PMI_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250925818926\\\/en\\\/328938\\\/22\\\/PMI_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/","og_locale":"en_US","og_type":"article","og_title":"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking - Pharma Trend","og_description":"Eight in 10 adults agree that adult smokers should have access to smoke-free options, while 76% worry that decisions are based on ideology rather than science and facts STAMFORD, Conn.&#8211;(BUSINESS WIRE)&#8211;A new international survey conducted by Povaddo and commissioned by Philip Morris International Inc. (NYSE: PM) reveals strong global support for smoke-free alternatives to cigarettes ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/","og_site_name":"Pharma Trend","article_published_time":"2025-09-25T11:05:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/22\/PMI_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking","datePublished":"2025-09-25T11:05:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/"},"wordCount":865,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/22\/PMI_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/","url":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/","name":"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/22\/PMI_logo.jpg","datePublished":"2025-09-25T11:05:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/22\/PMI_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250925818926\/en\/328938\/22\/PMI_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/survey-reveals-robust-public-support-for-better-alternatives-to-help-reduce-smoking\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Survey Reveals Robust Public Support for Better Alternatives to Help Reduce Smoking"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61922"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61922\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}